https://www.fool.com/investing/general/2006/03/23/wwe-reclaims-the-ring.aspx
https://www.fool.com/investing/value/2006/05/19/considering-a-costly-cognizant.aspx
https://www.fool.com/investing/small-cap/2004/12/30/lower-comps-plague-pier-1-imports.aspx
https://www.fool.com/investing/general/2005/10/28/booming-back-from-the-brink.aspx
https://www.fool.com/investing/high-growth/2005/06/15/a-new-test-for-quest.aspx
https://www.fool.com/investing/value/2005/04/26/intuit-hopes-to-book-it.aspx
https://www.fool.com/investing/value/2006/05/24/adobe-the-agile-acrobat.aspx
https://www.fool.com/investing/high-growth/2005/01/18/hp-should-fire-on-all-cylinders.aspx
https://www.fool.com/investing/small-cap/2005/03/29/krispy-kreme-worth-a-nibble.aspx
https://www.fool.com/investing/high-growth/2005/06/29/coffee-for-peets-sake.aspx
https://www.fool.com/investing/general/2006/06/09/chicos-still-charming.aspx
https://www.fool.com/investing/small-cap/2005/04/29/anixters-boring-quality.aspx
https://www.fool.com/investing/brokerage/2005/04/12/etrade-lean-and-mean-for-round-two.aspx
https://www.fool.com/investing/general/2006/04/25/norfolk-southern-worth-the-trip.aspx
https://www.fool.com/investing/small-cap/2006/03/09/applied-applies-itself.aspx
https://www.fool.com/investing/general/2006/06/21/corporate-executive-board-practicing-what-it-preac.aspx
https://www.fool.com/investing/general/2005/08/15/walgreens-prescription-for-success.aspx
